FDA Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQ
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), intends to issue a competitive Full and Open solicitation for a single-award Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract for Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) support services. This notice is a Presolicitation and includes a draft Request for Proposal (RFP) for industry review and planning purposes only. No proposals or responses are being requested at this time. The formal solicitation is anticipated to be issued on or about June 2026.
Scope of Work
The resultant IDIQ contract will support FDA enterprise-wide occupational safety, industrial hygiene, laboratory quality, biosafety, information systems, and training requirements. Services include, but are not limited to:
- Occupational safety and laboratory quality support
- Primary barrier equipment maintenance, repair, and certification
- Industrial hygiene assessments and program support
- Information and data systems support
- Training development and management
- Policy, compliance, and programmatic support
- BSL-3 laboratory re-verification and certification
- HVAC airflow and pressure differential testing
- Vaporized hydrogen peroxide (VHP) decontamination services
- Biosafety compliance assessments aligned with CDC, NIH, USDA/APHIS, OSHA, ANSI, ISO, and federal standards.
Primary performance will be at FDA Headquarters in Silver Spring, MD, with additional performance possible at FDA facilities nationwide.
Contract & Timeline
- Contract Type: Single-award Indefinite-Delivery/Indefinite-Quantity (IDIQ)
- Anticipated Ordering Period: Five (5) years from date of award
- Anticipated Maximum Contract Ceiling: $14,500,000
- Guaranteed Minimum: Satisfied through the initial task order
- Task Order Types: Firm-Fixed-Price (FFP), Time-and-Materials (T&M), Labor-Hour (LH), or hybrid basis
- Anticipated Formal Solicitation Release: On or about June 9, 2026
- Published Date: May 19, 2026
Set-Aside
This is a Full and Open competition; no specific set-aside is designated.
Evaluation (Anticipated)
Based on the draft RFP, proposals for the future solicitation will be evaluated on a best-value trade-off basis, considering:
- Corporate Experience
- Technical Approach
- Management Approach
- Past Performance
- Price
- Subcontracting Plan (for other than small businesses)
Non-price factors (Corporate Experience, Technical Approach, Management Approach, Past Performance) are combined and are significantly more important than price.
Additional Notes
This notice and the attached draft solicitation are for informational and planning purposes only. The Government is not requesting proposals, capability statements, comments, questions, or responses at this time. Offerors must be registered in the System for Award Management (SAM) at https://sam.gov at the time of proposal submission, prior to award, and throughout contract performance. Numerous attachments are incorporated into the draft, including a Performance Work Statement (PWS), pricing workbook, and security requirements.